000			02034 a2200505 4500
005			20250518015635.0
264		0	_c20190521
008			201905s 0 0 eng d
022			_a1476-5594
024	7		_a10.1038/s41388-018-0670-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aKarvonen, Hanna
245	0	0	_aWnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting. _h[electronic resource]
260			_bOncogene _c04 2019
300			_a3288-3300 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAniline Compounds _xpharmacology
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aHumans
650	0	4	_aOncogene Proteins, Fusion _xgenetics
650	0	4	_aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xgenetics
650	0	4	_aReceptor Tyrosine Kinase-like Orphan Receptors _xgenetics
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aSurvival Rate
650	0	4	_aTranslocation, Genetic _xdrug effects
650	0	4	_aUp-Regulation _xdrug effects
650	0	4	_aWnt Signaling Pathway _xdrug effects
650	0	4	_aWnt-5a Protein _xgenetics
650	0	4	_arhoA GTP-Binding Protein _xgenetics
700	1		_aPerttilä, Robert
700	1		_aNiininen, Wilhelmiina
700	1		_aHautanen, Veera
700	1		_aBarker, Harlan
700	1		_aMurumägi, Astrid
700	1		_aHeckman, Caroline A
700	1		_aUngureanu, Daniela
773	0		_tOncogene _gvol. 38 _gno. 17 _gp. 3288-3300
856	4	0	_uhttps://doi.org/10.1038/s41388-018-0670-9 _zAvailable from publisher's website
999			_c29242415 _d29242415